NEW YORK – After acquiring Lucira Health in a bankruptcy auction in 2023, Pfizer has decided to shut down the business, a Pfizer spokesperson told GenomeWeb.

Scientists in China have found a new coronavirus in bats that could possibly infect humans, but the risk remains low for now.

This Friday, February 28, marks five years since COVID-19 was first reported in Aotearoa New Zealand. At a population level, ...

In its Q3 2022 filing with the US Securities and Exchange Commission, Lucira noted that some of the delays were the result of a lack of clinical data. The firm at one point had to amend its ...

Long COVID is the chronic manifestation of lasting symptoms of SARS-CoV-2 infection that can last for at least 3 months, with shortness of breath and system inefficiency often remaining central issues ...

A team of Chinese researchers, led by 'batwoman' Shi Zhengli discovered a new bat coronavirus HKU5-Cov-2 which could ...

Anxiety and mood disorders are more prevalent among patients after COVID-19 critical illness vs after severe pneumonia unrelated to COVID-19.

Scientists explored the differences in heart inflammation caused by COVID-19, anti-COVID-19 vaccines, and other viral ...

A new mpox variant, clade 1b, is spreading rapidly in the DRC, with increased human-to-human transmission and risks for ...

For a majority of people, the COVID vaccine doesn’t cause adverse health effects — but a small percentage experience chronic ...

The CDC said in a statement on Monday that it does not believe the new coronavirus found in bats poses a concern to public health currently.

Receptors on B and T cells hint at what the immune system is targeting. An AI approach called Mal-ID developed increases diagnostic accuracy, particularly for autoimmune diseases.